A Republican bill with no cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "Healthy Technology Act of 2025," proposes amendments to the Federal Food, Drug, and Cosmetic Act. It aims to clarify the definition of a "practitioner licensed by law to administer such drug." Specifically, it seeks to include artificial intelligence and machine learning technologies as qualifying practitioners. For these technologies to qualify, they must be authorized by the relevant State statute. Additionally, they must be approved, cleared, or authorized by the Food and Drug Administration.
Yes· 3 of 5
- Scored +3
Does this make health care easier to get in general?
The bill expands the definition of a practitioner to include FDA-authorized AI and machine learning technologies, potentially increasing access to drug prescriptions.
- Scored +2
Would households on low incomes be better off under this?
By allowing AI-driven prescriptions, the bill may help increase healthcare efficiency and access for lower-income populations.
- Scored +2
Would people in cities be better off under this?
The integration of AI technology may improve digital healthcare delivery in urbanized technological hubs.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded definition of practitioner: The bill expands the term "practitioner licensed by law to administer such drug" to include artificial intelligence and machine learning technologies (Section 2). This could allow these technologies to participate in the prescription of drugs under specific conditions.
-
Standardized oversight: By requiring technologies to be authorized by a State and approved, cleared, or authorized by the FDA, the bill establishes a framework for their use (Section s 2(A) and 2(B)). This ensures that the technology meets specific regulatory standards before acting as a practitioner.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — By allowing AI-driven prescriptions, the bill may help increase healthcare efficiency and access for lower-income populations. Would people in cities be better off under this? — The integration of AI technology may improve digital healthcare delivery in urbanized technological hubs.
- Healthcare
- Does this make health care easier to get in general? — The bill expands the definition of a practitioner to include FDA-authorized AI and machine learning technologies, potentially increasing access to drug prescriptions.
- Governance And Ideology
- Does this give the federal government more power? — The bill requires AI technologies to undergo FDA approval or clearance to qualify as practitioners.
- Education And Technology
- Does this put more money into scientific research? — The bill provides a regulatory pathway for the integration of machine learning technology into healthcare practice.
- 1/7/2025
- Referred to the House Committee on Energy and Commerce.
- Introduced in House